Amphastar Pharmaceuticals, Inc. Shares Outstanding

Quick Answer

Amphastar Pharmaceuticals, Inc. reported Shares Outstanding of 45.65 million shares for fiscal year 2025.

Amphastar Pharmaceuticals, Inc. Shares Outstanding — Annual History

Fiscal Year Shares Outstanding YoY Change
2025 45.65M -4.1%
2024 47.62M -0.9%
2023 48.07M -0.1%
2022 48.11M +0.8%
2021 47.71M +0.5%
2020 47.50M +2.0%
2019 46.58M -0.1%
2018 46.63M +0.0%
2017 46.62M +0.8%
2016 46.25M +2.3%
2015 45.20M +1.2%
2014 44.65M +15.2%
2013 38.77M

Quarterly Shares Outstanding

Quarter Ending Shares Outstanding YoY QoQ
September 30, 2025 46.35M -4.2% -0.3%
June 30, 2025 46.49M -5.0% -2.5%
March 31, 2025 47.67M -2.4% +0.1%
December 31, 2024 47.62M -0.9% -1.6%
September 30, 2024 48.37M +1.0% -1.2%
June 30, 2024 48.96M +0.3% +0.2%
March 31, 2024 48.84M +1.4% +1.6%
December 31, 2023 48.07M -0.1% +0.4%
  • Amphastar Pharmaceuticals, Inc. showed a decrease of -4.1% in Shares Outstanding compared to the prior fiscal year.
  • Over the 2013–2025 period, Amphastar Pharmaceuticals, Inc.’s shares outstanding has grown by 17.7% (from 38.77 million shares to 45.65 million shares).
  • The most recent figure is from Amphastar Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment